nav-left cat-right
cat-right

Ortho-Clinical Diagnostics Announces Availability ...

The FINANCIAL — Ortho Clinical Diagnostics announced the availability of the Avioq HTLV-I/II Microelisa System assay, a new test developed in partnership with Avioq, Inc. to screen blood and organ donations for antibodies to human T-lymphotropic virus type I and II. Screening for antibodies to HTLV-I/II is required by the United States Food and Drug Administration for the nearly 16 million blood donations collected in...

Stool DNA Test for CRC Is Improving New Data Show ...

by Caroline Helwick San Francisco—New-generation stool DNA testing for colorectal cancer (CRC) screening offers “extraordinarily” high detection rates for cancers and precancers that are likely to progress, said David Ahlquist, MD, professor of medicine, Department of Gastroenterology and Hepatology at the Mayo Clinic, Rochester, Minn., who helped develop this approach and presented recent findings at the 2012 American...

Great Quest Receives Positive Results From Benefic...

VANCOUVER, BRITISH COLUMBIA, Mar 21, 2012 (MARKETWIRE via COMTEX) — John Clarke, CEO of Great Quest Metals Ltd. CA:GQ -4.69% (frankfurt:GQM) (“Great Quest” or the “Company”) is pleased to announce the successful completion of initial beneficiation tests carried out on the Tilemsi Phosphate Project in Eastern Mali by MINTEK South Africa and the Company’s consultant Gaya Resources Development...

Four anti-cancer compounds identified

Sydney: Four new anti-cancer compounds have shown promise in inhibiting the growth of tumours, according to a new approach. Jason Smith, doing his M.Phil. in biomolecular sciences from Macquarie University, combined existing knowledge of an enzyme with computational chemistry approach to identify novel (cancer) inhibitors. The enzyme (indoleamine 2,3-dioxygenase) has generated excitement amongst researchers due to its...

NMR Fine-Tuned for High-Content Metabolomics Scree...

Scientists report on the development of a nuclear magnetic resonance (NMR)-based method forscreening the metabolomic response of drug-treated mammalian cells to drug therapy. TheSanford-Burnham Medical Research Institute, and Rady Children’s Hospital investigators, say the highly sensitive, fast, and simple method is carried out in 96-well format, and could have particular utility as a method for high-throughput primary...

Research at A&M and Scripps finds HIV-killing...

COLLEGE STATION – A powerful topical preventative for HIV, the virus that causes AIDS, could be a step closer to clinical trials, thanks to a newly discovered molecular compound that research at Texas A&M University and the Scripps Research Institute shows dissolves the virus on contact. The ability of the synthetic compound known as “PD 404,182” to break apart the AIDS-causing virus before it can...
Page 20 of 34« First...10...1819202122...30...Last »